Literature DB >> 29222301

Optimizing the care model for an uncomplicated acute pain episode in sickle cell disease.

Paul Telfer1, Banu Kaya2.   

Abstract

The pathophysiology, clinical presentation, and natural history of acute pain in sickle cell disease are unique and require a disease-centered approach that also applies general principles of acute and chronic pain management. The majority of acute pain episodes are managed at home without the need to access health care. The long-term consequences of poorly treated acute pain include chronic pain, adverse effects of chronic opioid usage, psychological maladjustment, poor quality of life, and excessive health care utilization. There is no standard protocol for management of an acute pain crisis in either the hospital or the community. The assumptions that severe acute pain must be managed in the hospital with parenteral opioids and that strong opioids are needed for home management of pain need to be questioned. Pain management in the emergency department often does not meet acceptable standards, while chronic use of strong opioids is likely to result in opioid-induced hyperalgesia, exacerbation of chronic pain symptoms, and opioid dependency. We suggest that an integrated approach is needed to control the underlying condition, modify psychological responses, optimize social support, and ensure that health care services provide safe, effective, and prompt treatment of acute pain and appropriate management of chronic pain. This integrated approach should begin at an early age and continue through the adolescent, transition, and adult phases of the care model.
© 2016 by The American Society of Hematology. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29222301      PMCID: PMC6142581          DOI: 10.1182/asheducation-2017.1.525

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  59 in total

1.  Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).

Authors:  Russell E Ware; Ronald W Helms
Journal:  Blood       Date:  2012-02-07       Impact factor: 22.113

2.  A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults.

Authors:  Pablo Bartolucci; Tony El Murr; Françoise Roudot-Thoraval; Anoosha Habibi; Aline Santin; Bertrand Renaud; Violaine Noël; Marc Michel; Dora Bachir; Frédéric Galactéros; Bertrand Godeau
Journal:  Blood       Date:  2009-08-28       Impact factor: 22.113

3.  Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease.

Authors:  Carlton Dampier; Beth Ely; Darcy Brodecki; Camille Coleman; Leela Aertker; Jocelyn Andrel Sendecki; Benjamin Leiby; Karen Kesler; Terry Hyslop; Marie Stuart
Journal:  Pediatr Blood Cancer       Date:  2013-09-24       Impact factor: 3.167

4.  Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

Authors:  Michael R DeBaun; Mae Gordon; Robert C McKinstry; Michael J Noetzel; Desiree A White; Sharada A Sarnaik; Emily R Meier; Thomas H Howard; Suvankar Majumdar; Baba P D Inusa; Paul T Telfer; Melanie Kirby-Allen; Timothy L McCavit; Annie Kamdem; Gladstone Airewele; Gerald M Woods; Brian Berman; Julie A Panepinto; Beng R Fuh; Janet L Kwiatkowski; Allison A King; Jason M Fixler; Melissa M Rhodes; Alexis A Thompson; Mark E Heiny; Rupa C Redding-Lallinger; Fenella J Kirkham; Natalia Dixon; Corina E Gonzalez; Karen A Kalinyak; Charles T Quinn; John J Strouse; J Philip Miller; Harold Lehmann; Michael A Kraut; William S Ball; Deborah Hirtz; James F Casella
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

5.  The association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patients.

Authors:  Wally R Smith; Samir K Ballas; William F McCarthy; Robert L Bauserman; Paul S Swerdlow; Martin H Steinberg; Myron A Waclawiw
Journal:  Pain Med       Date:  2011-04-11       Impact factor: 3.750

6.  Cooperative Study of Sickle Cell Disease: Demographic and socioeconomic characteristics of patients and families with sickle cell disease.

Authors:  M D Farber; M Koshy; T R Kinney
Journal:  J Chronic Dis       Date:  1985

7.  Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management.

Authors:  Paula Tanabe; John W Hafner; Zoran Martinovich; Nicole Artz
Journal:  Acad Emerg Med       Date:  2012-04       Impact factor: 3.451

8.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

9.  Socio-economic deprivation and risk of emergency readmission and inpatient mortality in people with sickle cell disease in England: observational study.

Authors:  Ghida Aljuburi; Anthony A Laverty; Stuart A Green; Karen J Phekoo; Derek Bell; Azeem Majeed
Journal:  J Public Health (Oxf)       Date:  2013-10-29       Impact factor: 2.341

10.  Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease.

Authors:  Amanda M Brandow; Mark Nimmer; Timothy Simmons; T Charles Casper; Lawrence J Cook; Corrie E Chumpitazi; J Paul Scott; Julie A Panepinto; David C Brousseau
Journal:  Am J Hematol       Date:  2016-09-03       Impact factor: 10.047

View more
  4 in total

Review 1.  Neuropathic pain in sickle cell disease: measurement and management.

Authors:  Alexander Glaros; Amanda M Brandow
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

2.  The Role of Cognitive Behavioral Therapy in Opioid Use Reduction in Pediatric Sickle Cell Disease: Protocol for a Systematic Review.

Authors:  Ashaunta T Anderson; Nhu Tran; Kathryn Smith; Lorraine I Kelley-Quon
Journal:  JMIR Res Protoc       Date:  2019-07-17

3.  A non-injected opioid analgesia protocol for acute pain crisis in adolescents and adults with sickle cell disease.

Authors:  Paul Telfer; Jonathan Bestwick; James Elander; Arlene Osias; Nosheen Khalid; Imogen Skene; Ruben Nzouakou; Joanne Challands; Filipa Barroso; Banu Kaya
Journal:  Br J Pain       Date:  2021-08-02

Review 4.  Opioid Use in Patients With Sickle Cell Disease During a Vaso-Occlusive Crisis: A Systematic Review.

Authors:  Hadia Arzoun; Mirra Srinivasan; Isra Sahib; Jack Fondeur; Lisbeth Escudero Mendez; Raneem K Hamouda; Lubna Mohammed
Journal:  Cureus       Date:  2022-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.